THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2023 • 180 Life Sciences Corp. • Pharmaceutical preparations • Delaware
This Third Amendment to Employment Agreement (this “Amendment”), dated April 27, 2023, and effective for all purposes as of January 1, 2023 (the “Effective Date”), amends that certain Employment Agreement dated February 24, 2021, as amended by the First Amendment and Correction to Employment Agreement dated March 1, 2021 and Second Amendment to Employment Agreement dated May 26, 2021 (such Employment Agreement as amended to date, the “Employment Agreement”), as amended, by and between Ozan Pamir, an individual (“Pamir”) and 180 Life Sciences Corp., a Delaware corporation (“180 Life”), on, and subject to, the terms below. Certain capitalized terms used below but not otherwise defined shall have the meanings given to such terms in the Employment Agreement.
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2023 • 180 Life Sciences Corp. • Pharmaceutical preparations
This Third Amendment to Employment Agreement (“Amendment”), effective as of January 1, 2023 (the “Effective Date”), is entered into by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and Jonathan Rothbard (“Executive”) (collectively, the Company and Executive are the “Parties”).
THIRD AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2023 • 180 Life Sciences Corp. • Pharmaceutical preparations
This Third Amendment to Amended and Restated Employment Agreement (“Amendment”), effective as of January 1, 2023 (the “Effective Date”), is entered into by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and James N. Woody (“Executive”) (collectively, the Company and Executive are the “Parties”).
